Arif Bilal bought KALV
October 8, 2025 · Form 4 insider transaction
Arif Bilal bought 100,000 shares of KalVista Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderArif Bilal
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 8, 2025
Filing dateOctober 8, 2025
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests over a 4-year period: 25% vests on October 8, 2026, after which 1/48th of the total shares vest monthly, subject to reporting person's continued service through each vesting date.